U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

Expression data from early stage CRC patients' tumors [NanoString-Test]

(Submitter supplied) This study was conducted in order to identify biomarkers for a prognostic gene expression signature for metastases in early stage CRC.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL21950
131 Samples
Download data: RCC, TXT
Series
Accession:
GSE81985
ID:
200081985
2.

An FFPE-based prognostic signature to predict metastasis in stage I/II microsatellite stable colorectal cancer

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL570 GPL21950 GPL20712
573 Samples
Download data: CEL, CHP, RCC, TXT
Series
Accession:
GSE81986
ID:
200081986
3.

Expression data from early stage CRC patients' tumors [NanoString-Design]

(Submitter supplied) This study was conducted in order to identify biomarkers for a prognostic gene expression signature for metastases in early stage CRC.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL21950
144 Samples
Download data: RCC, TXT
Series
Accession:
GSE81983
ID:
200081983
4.

Expression data from early stage CRC patients' tumors [Agilent]

(Submitter supplied) This study was conducted in order to identify biomarkers for a prognostic gene expression signature for metastases in early stage CRC.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20712
148 Samples
Download data: TXT
Series
Accession:
GSE81981
ID:
200081981
5.

Expression data from early stage CRC patients' tumors [Affymetrix]

(Submitter supplied) This study was conducted in order to identify biomarkers for a prognostic gene expression signature for metastases in early stage CRC.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
150 Samples
Download data: CEL, CHP
Series
Accession:
GSE81980
ID:
200081980
6.

CGH profiles of primary colorecal cancer: metastasis-free, liver and peritoneal metastasis

(Submitter supplied) Accurate staging of colorectal cancer (CRC) with clinicopathological parameters is important for predicting prognosis and guiding treatment but provides us no information about organ site of metastases. Patterns of genomic aberrations in primary colorectal tumors may reveal a chromosomal signature for organ specific metastases.
Organism:
Homo sapiens
Type:
Genome variation profiling by array
Platform:
GPL4560
98 Samples
Download data: TXT
Series
Accession:
GSE20496
ID:
200020496
7.

The prognostic and predictive value of a six-microRNA-based classifier in stage II colon cancer

(Submitter supplied) microRNA profiling of colon tumor tissues vs adjacent normal tissues
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL17496
80 Samples
Download data: GPR
Series
Accession:
GSE49246
ID:
200049246
8.

Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array; Expression profiling by high throughput sequencing
Platforms:
GPL15048 GPL11154 GPL22404
326 Samples
Download data: CEL, RCC
Series
Accession:
GSE86566
ID:
200086566
9.

Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE RNA-Seq III)

(Submitter supplied) Background: The KRAS gene is mutated in about 40% of colorectal cancer (CRC) cases, which has been clinically validated as a predictive mutational marker of intrinsic resistatnce to anti-EGFR inhibitor (EGFRi) therapy. Since nearly 60% of patients with a wild type KRAS fail to respond to EGFRi treatment, there is a need to develop more reliable molecular signatures to better predict response. Here we address the challenge of adapting a gene expression signature predictive of RAS pathway activation, created using fresh frozen (FF) tissues, for use with more widely available formalin fixed paraffin-embedded (FFPE) tissues. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
54 Samples
Download data: XLSX
10.

Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE RNA-Seq II)

(Submitter supplied) Background: The KRAS gene is mutated in about 40% of colorectal cancer (CRC) cases, which has been clinically validated as a predictive mutational marker of intrinsic resistatnce to anti-EGFR inhibitor (EGFRi) therapy. Since nearly 60% of patients with a wild type KRAS fail to respond to EGFRi treatment, there is a need to develop more reliable molecular signatures to better predict response. Here we address the challenge of adapting a gene expression signature predictive of RAS pathway activation, created using fresh frozen (FF) tissues, for use with more widely available formalin fixed paraffin-embedded (FFPE) tissues. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
56 Samples
Download data: XLSX
11.

Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE RNA-Seq I)

(Submitter supplied) Background: The KRAS gene is mutated in about 40% of colorectal cancer (CRC) cases, which has been clinically validated as a predictive mutational marker of intrinsic resistatnce to anti-EGFR inhibitor (EGFRi) therapy. Since nearly 60% of patients with a wild type KRAS fail to respond to EGFRi treatment, there is a need to develop more reliable molecular signatures to better predict response. Here we address the challenge of adapting a gene expression signature predictive of RAS pathway activation, created using fresh frozen (FF) tissues, for use with more widely available formalin fixed paraffin-embedded (FFPE) tissues. more...
Organism:
Homo sapiens
Type:
Expression profiling by high throughput sequencing
Platform:
GPL11154
54 Samples
Download data: XLSX
12.

Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE NanoString)

(Submitter supplied) Background: The KRAS gene is mutated in about 40% of colorectal cancer (CRC) cases, which has been clinically validated as a predictive mutational marker of intrinsic resistatnce to anti-EGFR inhibitor (EGFRi) therapy. Since nearly 60% of patients with a wild type KRAS fail to respond to EGFRi treatment, there is a need to develop more reliable molecular signatures to better predict response. Here we address the challenge of adapting a gene expression signature predictive of RAS pathway activation, created using fresh frozen (FF) tissues, for use with more widely available formalin fixed paraffin-embedded (FFPE) tissues. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL22404
54 Samples
Download data: RCC
Series
Accession:
GSE86561
ID:
200086561
13.

Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE Affymetrix)

(Submitter supplied) Background: The KRAS gene is mutated in about 40% of colorectal cancer (CRC) cases, which has been clinically validated as a predictive mutational marker of intrinsic resistatnce to anti-EGFR inhibitor (EGFRi) therapy. Since nearly 60% of patients with a wild type KRAS fail to respond to EGFRi treatment, there is a need to develop more reliable molecular signatures to better predict response. Here we address the challenge of adapting a gene expression signature predictive of RAS pathway activation, created using fresh frozen (FF) tissues, for use with more widely available formalin fixed paraffin-embedded (FFPE) tissues. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL15048
54 Samples
Download data: CEL
Series
Accession:
GSE86559
ID:
200086559
14.

Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FF Affymetrix)

(Submitter supplied) Background: The KRAS gene is mutated in about 40% of colorectal cancer (CRC) cases, which has been clinically validated as a predictive mutational marker of intrinsic resistatnce to anti-EGFR inhibitor (EGFRi) therapy. Since nearly 60% of patients with a wild type KRAS fail to respond to EGFRi treatment, there is a need to develop more reliable molecular signatures to better predict response. Here we address the challenge of adapting a gene expression signature predictive of RAS pathway activation, created using fresh frozen (FF) tissues, for use with more widely available formalin fixed paraffin-embedded (FFPE) tissues. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL15048
54 Samples
Download data: CEL
Series
Accession:
GSE86557
ID:
200086557
15.

Global gene expression analysis of fresh-frozen, furan-exposed mouse liver using RNA-seq [polyA enrichment]

(Submitter supplied) Furan is a mouse and rat hepatocarcinogen. We sought to determine if furan-induced gene expression changes could be detected in paired fresh-frozen and formalin-fixed paraffin embedded (FFPE) samples using RNA-seq (polyA-enrichment protocol). All samples in this study (fresh-frozen, 18 hours in formalin, 3 weeks in formalin) were also examined using one- and two-colour microarrays and RNA-seq (ribo-depletion protocol) in order to determine the effect of the technology on gene expression profiles.
Organism:
Mus musculus
Type:
Expression profiling by high throughput sequencing
Platform:
GPL13112
24 Samples
Download data: TXT
Series
Accession:
GSE64371
ID:
200064371
16.

Global gene expression analysis of fresh-frozen, furan-exposed mouse liver using RNA-seq [ribo-depletion]

(Submitter supplied) Furan is a mouse and rat hepatocarcinogen. We sought to determine if furan-induced gene expression changes could be detected in paired fresh-frozen and formalin-fixed paraffin embedded (FFPE) samples using RNA-seq (ribo-depletion protocol). All samples in this study (fresh-frozen, 18 hours in formalin, 3 weeks in formalin) were also examined using one- and two-colour microarrays and RNA-seq (polyA-enrichment protocol) in order to determine the effect of the technology on gene expression profiles.
Organism:
Mus musculus
Type:
Expression profiling by high throughput sequencing
Platform:
GPL13112
24 Samples
Download data: TXT
Series
Accession:
GSE64370
ID:
200064370
17.

Global gene expression analysis in paired fresh-frozen and FFPE furan-exposed mouse liver samples

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Mus musculus
Type:
Expression profiling by array; Expression profiling by high throughput sequencing
Platforms:
GPL13112 GPL10787
122 Samples
Download data: TXT, XLSX
Series
Accession:
GSE62843
ID:
200062843
18.

Global gene expression analysis of fresh-frozen, furan-exposed mouse liver using one-colour Agilent microarrays

(Submitter supplied) Furan is a mouse and rat hepatocarcinogen. We sought to determine if furan-induced gene expression changes could be detected in paired fresh-frozen and formalin-fixed paraffin embedded (FFPE) samples using one-colour microarrays. All samples in this study (fresh-frozen, 18 hours in formalin, 3 weeks in formalin) were also examined using two-colour microarrays and RNA-seq (ribo-depletion and polyA-enrichment protocols) in order to determine the effect of the technology on gene expression profiles.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL10787
8 Samples
Download data: TXT
Series
Accession:
GSE62842
ID:
200062842
19.

Global gene expression analysis of formalin-fixed paraffin-embedded (FFPE), furan-exposed mouse liver using one-colour Agilent microarrays

(Submitter supplied) Furan is a mouse and rat hepatocarcinogen. We sought to determine if furan-induced gene expression changes could be detected in paired fresh-frozen and formalin-fixed paraffin embedded (FFPE) samples using one-colour microarrays. To determine the effect of time-in-formalin on gene expression signatures we performed microarray analysis of livers that were fixed in formalin for 18 hours or 3 weeks. All samples (fresh-frozen, 18 hours in formalin, 3 weeks in formalin) were also examined using two-colour microarrays and RNA-seq (ribo-depletion and polyA-enrichment protocols) in order to determine the effect of the technology on gene expression profiles.
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL10787
50 Samples
Download data: TXT
Series
Accession:
GSE62840
ID:
200062840
20.

Global gene expression analysis of formalin-fixed paraffin-embedded (FFPE), furan-exposed mouse liver using two-colour Agilent microarrays

(Submitter supplied) Furan is a mouse and rat hepatocarcinogen. We sought to determine if furan-induced gene expression changes could be detected in paired fresh-frozen (GSE48644) and formalin-fixed paraffin embedded (FFPE; this study) samples using two-colour microarrays. To determine the effect of time-in-formalin on gene expression signatures we performed microarray analysis of livers that were fixed in formalin for 18 hours or 3 weeks. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL10787
16 Samples
Download data: TXT
Series
Accession:
GSE62838
ID:
200062838
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=3|blobid=MCID_6661a9dcbb845b085b85b2bb|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center